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The metabolism of [U-14C] phenylmercury acetate was studied in the rat. After a single subcutaneous dose a small proportion is excreted unchanged in urine, and a larger amount in bile with some resorption from the gut. The greater part of the dose is broken down in the tissues to yield inorganic mercury which is excreted mainly in faeces, and conjugates of phenol and quinol are excreted in urine. In experiments in vitro phenylmercury is broken down by liver homogenates to release inorganic mercury and benzene; this reaction is effected by the soluble, but not the microsomal, fraction and does not require NADPH or NADH. No elemental mercury is formed under these conditions. It is probable that this reaction occurs in vivo and the benzene produced is rapidly converted into phenol and quinol by microsomal enzymes.
The rapid release of inorganic mercury from phenylmercury in the body has been demonstrated by Miller et al. (1960) and by Gage (1964) , using analytical methods capable of distinguishing between organic and inorganic mercury. The same conclusion may be reached from other investigations (Friberg et al., 1957; Swensson et al., 1959; Ulfvarson, 1962; Berlin & Ullberg, 1963; Ellis & Fang, 1967) which have shown that the administration ofphenylmercury or inorganic mercury labelled with 203Hg to animals leads to a similar distribution of radioactivity in the tissues and excreta. Gage & Swan (1961) have suggested that this rapid metabolism of phenylmercury is responsible for its failure to produce the severe neurotoxic effects characteristic of methylmercury, which is much more stable in the body. A similar hypothesis has been proposed to account for the absence of such effects with methoxyethylmercury The residual hydrolysed urine after steam distillation was extracted with ether, and the extract was shaken successively with saturated aq. NaHCO3 and M-NaOH. The aqueous layers were acidified and re-extracted into ether and the extract was examined by g.l.c. and t.l.c. as described above. The residual urine was then made 5M with respect to H2SO4, boiled under reflux for 3h, and processed as described above.
In control experiments, it was established that no radioactivity was recovered as steam-volatile material when a solution of [U-'4C]phenylmercury acetate (1mg) in rat urine (25ml) was subjected to prolonged hydrolysis (3h) with 5M-H2SO4.
Identification of mercury-containing metabolites. Urine and bile from rats dosed with [U-14C]phenylmercury acetate were extracted with a solution of dithizone in chloroform , and livers were extracted by the method of Tatton & Wagstaffe (1969) . The dithizonates were chromatographed on silica gel G (Gage, 1961 
in toluene (1 litre)] and N2 was passed through the train at 50ml/min. The radioactivity in the organic solution was measured in each of these procedures, and compared with the amount of inorganic mercury in the solution. In other experiments, the volatile metabolite obtained by method (c) was trapped in CS2 cooled in an ice-salt mixture, and the solvent was examined by g.l.c. as described above. These experiments were made with and without added NADH, and the mercury content of the solution was also measured before and after the aspiration period.
Analytical methods
The inorganic and total mercury content in urine and bile and in a 10% (w/v) homogenate of liver, kidney and faeces in aq. 1 % sucrose were determined by the methods of Gage & Warren (1970) . Radioactivity was measured as described by Daniel & Gage (1965) . Radioactivity in expired air before and after pyrolysis was determined as described by .
Results
Excretion of radioactivity and mercury Table 1 shows that after a single subcutaneous dose of [U-14C]phenylmercury acetate to rats, most of the radioactivity appeared in urine, with little in the faeces, but the major route of mercury excretion was through the faeces. The difference between total and inorganic mercury in urine on the first few days indicates a small excretion of organic mercury (about 2.5% of the dose); the low radioactivity of faeces indicates that most or all of the mercury in faeces was inorganic. At the end of this experiment 10.7% of the dose was found as inorganic mercury in the kidney and 2.9% in the liver, making the total recovery of mercury in the excreta and tissues examined to be 78.7 %. No 14CO2 was detected in the exhaled air in 48h. In a separate experiment, 5.5% of the radioactivity was excreted in 48h as volatile material which was recovered as 14CO2 after pyrolysis. The total excretion of radioactivity in urine, faeces and expired air was 94.1 %.
The biliary excretion of both radioactivity and mercury after a single subcutaneous dose of [U-14C]-phenylmercury acetate was considerable ( Table 2) . Most of the mercury excreted during the first 48h was organic; thereafter the proportion of organic mercury decreased.
Accumulation in tissues After a single dose of phenylmercury acetate the mercury content of liver and kidneys increased over 24h (Table 3) ; at 2h more than half of this was organic, but at 24h very little organic mercury remained.
Identification ofmercury-free metabolites in urine
The distribution ofradioactivity from the fractionation of hydrolysed urine is shown in Scheme 1.
Phenol was identified in the steam distillates, which contained no other radioactive metabolites. The other fractions did not contain phenol and were too impure to be characterized by mass spectroscopy.
From the specific radioactivities of the toluene p-sulphonates isolated from hydrolysed urine to which phenol or quinol had been added, the percentage of radioactivity as phenol and quinol in the urine was calculated (Table 4) . Identification ofmercury compounds in urine, bile and liver Chromatography of the dithizone extracts of urine, bile and liver homogenates showed that inorganic mercury and phenylmercury were present. No trace of o-or p-hydroxyphenylmercury could be detected. 2.4 1.3 0.9 0.5 0.9 87.0 1.2 1.2 1.3 0.9 0.4 1.0 10.0 1.4 1.4
1.3 0.9 0.4 1.0 12.6 0.4 0.7 0.5 0 10.6 6.7 8.5 3.9 10.6 5.8 3.6 1.6 2.8 52.5 A considerable proportion of the dose is excreted as phenylmercury in bile, though less than was observed with methoxyethylmercury . As the biliary excretion is more rapid than the faecal excretion, and no radioactivity was found in faeces, the phenylmercury must be partly resorbed and partly degraded in the gut. (Table 2) , so a mercury-free metabolite must be excreted by this route, presumably phenyl glucuronide. On the basis of the experiments demonstrating the excretion of conjugated phenol after the administration of phenylmercury acetate, proposed the hypothesis that phenylmercury is hydroxylated by the microsomal fraction to give p-hydroxyphenylmercury, which, according to 1972 Wiener et al. (1962) , is unstable in the presence of cysteine at low pH values, and that fission of the carbon-mercury bond in vivo might not therefore involve an enzyme system. It now seems certain that this hypothesis is not correct, as attempts to demonstrate the presence of o-or p-hydroxyphenylmercury in urine and bile have proved negative, and the release in vitro of inorganic mercury by liver homogenates is effective in the absence of the microsomal fraction. The evidence now shows that benzene is the primary metabolite; this is then converted by microsomal hydroxylation into phenol with a minor amount of quinol, which are excreted as conjugates. This conforms with the metabolic pathway of benzene in the rabbit found by Parke & Williams (1953) . Furukawa et al. (1969) and Tonomura & Kanzai (1969) have shown that a cell-free extract of a mercury-resistant pseudomonad is capable of splitting phenylmercury into benzene and metallic mercury. They claim that this reaction requires NADH, or an NADH-generating system, and thioglycollate. Our results have shown that breakdown of phenylmercury by a liver preparation does not require NADH and that no volatilization ofmetallic mercury occurs with or without added NADH. This breakdown to benzene and mercuric ion can be represented by the addition of a proton: C6HsHg+ + H+ = C6H6 +Hg2+
[Although phenylmercury acetate is stable in weakly acid solutions in the presence of cysteine at 37°C (Wiener et al., 1962) , mercuric ions are readily liberated when the solution is boiled for 1 h (Gage & Warren, 1970) .] The reaction in vivo can be regarded as a hydrolysis, rather than the reduction proposed by Tonomura & Kanzaki (1969) . It is possible that different mechanisms operate in the two systems, but an alternative explanation is that in both, mercuric ion is first produced, and that in the microbiological preparation this is rapidly reduced to elemental mercury by an enzyme requiring NADH. Magos et al. (1964) showed that some micro-organisms, including Pseudomonas aeruginosa, could convert mercuric ion into metallic mercury.
The mechanism of the reaction identified in this present study clearly requires further investigation. Apart from phenylmercury acetate, inorganic mercury is also released when either methoxyethylmercury chloride or p-chloromercuribenzoate, but not methylmercury or ethylmercury salts, are incubated with supernatant F3.
